Osteoblast Role in Rheumatic Diseases
Open Access
- 15 June 2017
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (6) , 1272
Abstract
Alterations in osteoblast growth, differentiation and activity play a role in the pathogenesis of several rheumatic diseases, such as rheumatoid arthritis, spondyloarthritides, osteoarthritis, and osteoporosis. In fact, in these rheumatic diseases, abnormal activity of Wnt signaling, receptor activator of nuclear factor-κB (RANK)-RANK ligand (RANKL)-osteoprotegerin (OPG) signaling, bone morphogenetic proteins (BMPs) pathway and other mechanisms have been described in osteoblasts. This review article is focused on current knowledge on the role of osteoblast dysregulation occurring in rheumatic diseases.Keywords
This publication has 117 references indexed in Scilit:
- Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblastsClinical and Experimental Medicine, 2011
- R-spondins are newly recognized players in osteoarthritis that regulate Wnt signaling in osteoblastsArthritis & Rheumatism, 2011
- Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expressionArthritis Research & Therapy, 2010
- Osteocytes, mechanosensing and Wnt signalingBone, 2008
- RANKL-stimulated TNFα production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathwaysBiochemical and Biophysical Research Communications, 2007
- The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsBlood, 2007
- Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjectsClinical Rheumatology, 2005
- Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosisBiochemical and Biophysical Research Communications, 2004
- Osteoclast differentiation and activationNature, 2003
- Tumor necrosis factor‐α mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism†Journal of Cellular Biochemistry, 2001